ReviewMetabolomics : Official journal of the Metabolomic Society2026
What's in a name? Metabolite identification: challenges and pitfalls in untargeted metabolomics.
Review in Metabolomics : Official journal of the Metabolomic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- GinorMass: A Tandem Mass Spectral Repository of 24 Million Spectra From One Molecule.Analytical science advances · 2026Article
- Comparative Phytochemical Profiling, Antioxidant Activity, and Chondrocyte Cytocompatibility of Water and Ethanolic Extracts from Different Organs of Golden Gardenia (Antioxidants (Basel, Switzerland) · 2026Article
- Untargeted Blubber Metabolomics Reveals Biochemical Signatures Associated with Physiological Status in Live, Free-Ranging Bottlenose Dolphins.Metabolites · 2026Article
- A Reporting Guideline for Observational Studies in Metabolomic Epidemiology: Explanation and Elaboration of the Strobe-MetEpi Checklist.Research square · 2026Article
- Linking antioxidant activity to strain-specific exometabolomic profiles in probioticCurrent research in food science · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
Abstract
backgroundThe aim of metabolic phenotyping (metabotyping) is to discover and identify metabolites (including lipids) that can be used to characterize biological samples and differentiate between different physiological states. The identification of the metabolites responsible for this differentiation is essential if mechanistic understanding is to be obtained. Confident metabolite identification arguably represents the most important outcome of untargeted metabolomics studies but currently the standards used for metabolite identification reported in many publications do not strictly follow the various published guidelines and thus these identifications lack sufficient proof. AIM OF REVIEW: In this perspective we define problems that currently plague the field of metabolite identification using MS-based techniques, particularly LC-MS, in untargeted metabolic phenotyping. Despite considerable efforts by the community (researchers, instrument manufacturers, software, and database developers) this continues to be a contentious and error-prone step in the metabolomics workflow. The majority of publications provide only sparse data on the evidence for metabolic markers "identified" and we have observed an alarming increase in the frequency of erroneous metabolite identifications. Here, we describe the problem and provide several illustrative case studies. Our goal is to raise awareness and highlight the issue of poor metabolite identification, since it is also increasingly apparent that these errors are not always recognised during the reviewing process, such that papers with potentially erroneous metabolite identities reach publication. KEY SCIENTIFIC CONCEPTS OF REVIEW: Poor metabolite identification potentially represents an existential threat to the credibility of untargeted "discovery" metabolomics and can pollute the literature. Here we describe the aetiology of the problem and explain how and why this issue affects the field. We argue that coordinated action is required by researchers, database managers, scientific societies and the reviewers, editors and publishers of scientific journals to both acknowledge and address this important problem.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.